Donald A. Bergstrom, President, R&D at Relay Therapeutics, Inc. (RLAY), sold 31,562 shares at $3.00 ($95K) on 2025-04-30, disclosed to the SEC on 2025-04-30.
Open-market sale of $95k RLAY by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.17 | 4,090 | $13K | 13.6% |
| 2 | $3.00 | 27,472 | $82K | 86.4% |
| Total | $3.02 avg | 31,562 | $95K | 100% |
| Filing → |
| RLAY | SELL | 2026-07-08 | $162K | — | Filing → |
| RLAY | SELL | 2026-06-24 | $1.6M | — | Filing → |
| RLAY | SELL | 2026-04-30 | $22K | — | Filing → |